ArticleCureus2025
A Comparison of Tumor Tracking Accuracy Using Real-Time Adaptive Motion Management on Helical Versus Robotic Radiotherapy Platforms: An Interdisciplinary Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of daily volumetric imaging on target tracking without fiducial markers during robotic treatment of pancreas.Physics in medicine and biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Real-time adaptive motion management (RTAMM) systems have enhanced the accuracy of tumor tracking during radiotherapy. This study aimed to investigate the tumor tracking accuracy of helical tomotherapy and robotic CyberKnife systems. The study objective was to assess the tumor tracking accuracy of RTAMM in helical and robotic radiotherapy systems and determine their clinical relevance in treating tumors with complicated motion. Methodology This retrospective study analyzed the clinical and imaging data of 60 patients with lung or liver tumors treated with TomoTherapy or CyberKnife between March 2024 and January 2025. Tumor positional deviations were tracked and recorded in real time using onboard imaging. Mean deviations and standard deviations were calculated, and independent t-tests were used to compare tracking accuracy. Results CyberKnife demonstrated superior tumor tracking accuracy, with a mean deviation of 0.8 mm (±0.2 mm) versus 2.3 mm (±0.4 mm). CyberKnife outperformed tomotherapy in tumors exhibiting high motion, with a statistically significant difference (p < 0.01). Conclusions Robotic CyberKnife systems provide more accurate tumor tracking than helical tomotherapy systems, particularly for tumors with complex motions, validating their use in precision radiation therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.